Heron Therapeutics | HRTX - Ebitda





Ebitda 変化する 日付
ALKERMES USD 120.06M 19.15M 2026-09
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amarin USD 12.54M 28.57M 2025-06
ANI Pharmaceuticals USD 83.3M 11.7M 2026-09
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
Eisai JPY 25.94B 8.21B 2026-09
GlaxoSmithKline GBP 3.51B 734M 2026-06
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -80.97M 93.7M 2026-09
Ligand Pharmaceuticals USD 74.27M 88.56M 2026-06
Merck USD 1.42B 2.97B 2026-06
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 50.45M 1.78M 2026-09
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Veracyte USD 41.24M 2.72M 2026-09
Vertex Pharmaceuticals USD 888.6M 436.6M 2026-09